Nachrichten zur Acadia Pharmaceuticals Inc. Aktie

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys Now, Securities Fraud Class Action Filed

SAN FRANCISCO, April 22, 2021 /PRNewswire/ -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to…

Pomerantz Law Firm Announces the Filing of a Class Action against Acadia Pharmaceuticals Inc. and Certain Officers - ACAD

NEW YORK, April 19, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acadia…

Circling Back On Acadia Pharmaceuticals

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Tesla, Delta rise; Acadia Pharmaceuticals, Occidental fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:...…

Mid-Day Market Update: Leaf Group Jumps Following Acquisition News; ACADIA Pharmaceuticals Shares Slide

Midway through trading Monday, the Dow traded up 1.16% to 33,536.76 while the NASDAQ rose 1.37% to 13,664.49. The S&P…

Chembio Diagnostics, Nano-X Imaging leads healthcare gainers; Molecular Templates, ACADIA Pharmaceuticals among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Acadia Pharma, Bio-path And Cidara Are Moving Today

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Bio-Path Holdings, Inc. (NASDAQ: BPTH) and Cidara Therapeutics, Inc. read more...…

ACADIA PHARMACEUTICALS INC: 8-K Report

8-K...…

Acadia Pharma drops as FDA rejects Nuplazid label expansion

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moving Average Crossover Alert: ACADIA Pharma

ACADIA Pharmaceuticals (ACAD) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends…

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys

San Francisco, California--(Newsfile Corp. - March 15, 2021) - Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD

New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD

NEW YORK , March 12, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf…

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys

SAN FRANCISCO , March 9, 2021 /PRNewswire/ -- Hagens Berman invites Acadia Pharmaceuticals Inc.…

Why 2 Acadia Pharma Analysts Are Bracing For FDA Rejection Of Nuplazid In Dementia

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) said late Monday it was notified by the Food and Drug Administration of deficiencies in…

Mid-Day Market Update: Gold Rises Over 2%; ACADIA Pharmaceuticals Shares Plunge

Midway through trading Tuesday, the Dow traded up 0.82% to 32,061.95 while the NASDAQ rose 3.5% to 13,051.08. The S&P…

SHAREHOLDER ALERT: Acadia Pharmaceuticals Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - March 9, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces…

Auris Medical, AnPac Bio-Medical Science leads healthcare gainers; ACADIA Pharmaceuticals, Graybug Vision among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Acadia Pharmaceuticals Stock Is Crashing Today

An unexpected regulatory setback is weighing on the biotechs shares....…

Premarket Movers Tuesday - Second Sight, Acadia Pharma, GameStop, Tesla

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals stock leads premarket losers after FDA finds undisclosed deficiencies in NDA

Shares of Acadia Pharmaceuticals Inc. plunged 42.1% to pace all premarket decliners Tuesday, in the wake of the company's…

ACADIA PHARMACEUTICALS INC: 8-K Report

8-K...…

ACADIA Pharmaceuticals, Inc. (ACAD) Presents at Cowen Healthcare Broker Conference Call - (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ROCE Insights For ACADIA Pharmaceuticals

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported Q4 sales of $121.01 million. Earnings fell to a loss of $67.16 million, resulting in a…

ACADIA Pharmaceuticals Inc. 2020 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q4 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals (ACAD) Reports Q4 Loss, Lags Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of 12.50% and -1.52%, respectively, for the quarter ended December 2020. Do the…

ACADIA PHARMACEUTICALS INC: 8-K Report

8-K...…

Acadia Pharmaceuticals: Some Thoughts Ahead Of 2021

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals upgraded to strong buy from outperform at Raymond James

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of -42.11% and 1.52%, respectively, for the quarter ended September 2020. Do the…

ACADIA PHARMACEUTICALS INC: 10-Q Report

10-Q...…

ACADIA PHARMACEUTICALS INC: 8-K Report

8-K...…

ACADIA PHARMACEUTICALS INC: 8-K Report

FORM 8-K...…

ACADIA Pharmaceuticals, Inc. (ACAD) CEO Steve Davis Presents at Cantor Virtual Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACADIA Pharmaceuticals, Inc. (ACAD) Presents at Cantor Virtual Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

(ACAD) Alert: Johnson Fistel Announces Shareholder Class Action Against ACADIA Pharmaceuticals Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses?

SAN DIEGO , Sept. 5, 2020 /PRNewswire/ -- Johnson Fistel …